MarketsStocksNORRIS
NO

Norris Medicines Ltd.

NSE: NORRISBSE: 524414Services
Download Research Report7-page PDF
13.20
-0.53%
NSE · auto-updates while market open
Mkt Cap
₹13 Cr
P / E
62.7
P / B
-
ROE
-
52W High
₹20.76
52W Low
₹12.00
Key Metrics
Market Cap
₹13 Cr
P / E
62.67
P / B
-
EV / EBITDA
52.16
ROCE
12.4%
ROE
-
Debt / Equity
-
Book Value
₹-15.26
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
34.0%
Revenue · ₹ Cr
9
FY22
8
FY23
6
FY24
6
FY25
8
FY26
Net Profit · ₹ Cr
-3
-2
-1
-1
0
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹-3.3
₹-1.8
₹-1.2
FY22FY23FY24
Q1 2026 snapshot
Sales
₹1 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.05
Scorecard · 7 axes
Quality
Bad
25/100
Valuation
Bad
62.7×
Growth
Bad
-1.8%
Profitability
Weak
6.2%
Performance
Bad
-31.7%
Entry Point
Good
64%
Red Flags
Strong
0 flags
Shareholding Pattern
34.0%Promoter
Promoter34.0%
DII0.1%
Public65.9%
Quarterly Results · ₹ Cr
QuarterFY24 09QFY24 12QFY25 03QFY25 06QFY25 12QFY26 03Q
Revenue1.271.112.771.483.271.43
Net Profit-0.361-0.282-0.229-0.310.6970.051
NPM %-28.4%-25.4%-8.2%-21.0%21.3%3.5%
AlertPre-trade